The Arx Research team consists of professionals armed with the knowledge and expertise to deliver high-quality research to our clients. We are committed to fostering long-term relationships with you and delivering meaningful intelligence to help your business.
Yanis Saradjian has served as the Chief Executive Officer of Arx Research, LLC since June 2014. He directs the company’s planning, strategy and business development initiatives. Mr. Saradjian conducts customized consulting engagements for Fortune 500 Life Sciences and Consumer Goods Companies. He has over twenty years of direct leadership experience in business operations and strategy consulting with significant project management, strategy formulation and deployment.
Prior to founding Arx Research, Mr. Saradjian served as Director of Consulting for a boutique corporate research firm and prior to this position as Project Director and Senior Consultant for various consultancies. Mr. Saradjian has worked with more than 200 clients, conducting operational assessments and reorganizations, benchmarking and development of solutions in the areas of medical affairs, thought leader management, clinical development and commercial groups.
Mr. Saradjian’s insights have been mentioned in numerous media (PharmaVoice, SCIP, EyeforPharma, Cincinnati Business Courier, ExecuNet, FirstWord Dossier, China Sourcing, Cardiovascular Business, Pharmacy Choice among others). He has written several white papers and conducted numerous webinars on the Medical Liaison function and Thought Leader Management topics. Mr. Saradjian has also provided his expertise through workshops and panel participations (Canadian Healthcare Licensing Association, Philips Healthcare) as well as speaking at various conferences on Thought Leader Management and Regulatory Affairs subjects.
Mr. Saradjian received his Master’s in Business Administration from the University of Sherbrooke in Canada, has a Certification in Finance from the Ecole des HEC Montreal, Canada and executive education on Innovation from Babson College in Wellesley and Global Strategic Management from Harvard University in Cambridge, MA.
View profile and connect on LinkedIn
Jordan Stone, PhD
Independent Writer and Research Contributor
Jordan Stone has researched, published and presented on a range of pharmaceutical business functions, including MSLs, Medical Affairs, Thought Leader Management, KOL Fair-Market Value (FMV), and Regulatory Affairs. He was previously Senior Research Analyst and lead author for topical research studies in the life sciences. Jordan has also served as project manager in numerous consulting engagements. He has been writing and publishing on industry trends since 2007. Jordan did his doctoral work at the University of Georgia.
View profile and connect on LinkedIn
Arx Research serves clients in the life science sectors worldwide. Our areas of research focus on the operational and strategic components of functions such as medical affairs, clinical development, marketing, sales and commercialization, portfolio management, and business development.
Our network of dedicated research partners spans over 70 countries and consists of over 50,000 executives in all areas of life sciences.
Arx Research analysts use primary research resources to develop studies and conduct customized research initiatives. Secondary sources are sometimes used to confirm and support primary data findings when necessary. The quantitative and qualitative data are collected through surveys and interviews conducted with executives, thought leaders, physicians and life science sector experts where and when warranted, across North America, South America, Europe and Asia-Pacific countries.
The output of findings presented through the research is designed to investigate, outline, show, establish or demonstrate industry trends, metrics or benchmark. The data are generally segmented based on factors deemed having the most meaning to our clients.
We protect the identity and privacy of study participants and therefore blind their personal information and the organizations they belong to. This allows Arx Research to collect unbiased information, provided confidently from participants.
Our mission is to help our clients make remarkable improvements to their operations and establish enduring management principles to enhance capabilities and performance through the application of hard-to-get industry insights.
We operate with integrity, commitment and confidentiality.